Briacell Therapeutics Corp shares owned by UBS Group
Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTXW) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Briacell Therapeutics Corp
Tip: Access up to 7 years of quarterly data
All positions including Briacell Therapeutics Corp held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Briacell Therapeutics Corp by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $12k | 29k | 0.41 |
2024-06-30 | $2.7k | 10k | 0.27 |
2023-09-30 | $350 | 142 | 2.47 |
2022-12-31 | $3.0k | 1.4k | 2.06 |
2022-09-30 | $8.0k | 2.9k | 2.73 |
2022-06-30 | $13k | 5.1k | 2.56 |
2022-03-31 | $6.0k | 1.1k | 5.28 |
2021-09-30 | $10k | 2.1k | 4.80 |
Top funds holding Briacell Therapeutics Corp
View all funds holding Briacell Therapeutics Corp